Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Protein p53. Found 19 abstracts

Gate L, Majumdar RS, Lunk A, Tew KD. Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice. International journal of cancer. 2005 Jan;113(1):29-35.
Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol. 2005 Feb;7(2):165-71.
Biade S, Murphy ME. Differential display techniques to identify tumor suppressor gene pathways. Methods Mol Biol. 2003 Jan;222:481-90.
Murphy ME. The thousand doors that lead to death: p53-dependent repression and apoptosis. Cancer Biol Ther. 2003 Jul;2(4):381-2.
Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. The Journal of biological chemistry. 2002 Feb;277(5):3247-57.
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol. 2002 Nov;22(22):7831-41.
Knudson AG. Cancer genetics. Am J Med Genet. 2002 Jul 22;111(1):96-102.
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28.
Osman I, Sherman E, Singh B, Venkatraman E, Zelefsky M, Bosl G, Scher H, Shah J, Shaha A, Kraus D, Cordon-Cardo C, Pfister DG. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol. 2002 Jul;20(13):2980-7.
Guerardel C, Deltour S, Pinte S, Monte D, Begue A, Godwin AK, Leprince D. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. The Journal of biological chemistry. 2001 Feb 02;276(5):3078-89.
Johnson RA, Ince TA, Scotto KW. Transcriptional repression by p53 through direct binding to a novel DNA element. The Journal of biological chemistry. 2001 Jul 20;276(29):27716-20.
Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol. 2001 Feb;21(4):1297-310.
Shen H, Chen ZJ, Zilfou JT, Hopper E, Murphy M, Tew KD. Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs. The Journal of pharmacology and experimental therapeutics. 2001 Jun;297(3):1067-73.
Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol. 2001 Feb;11(1):31-8.
Zilfou JT, Hoffman WH, Sank M, George DL, Murphy M. The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol Cell Biol. 2001 Jun;21(12):3974-85.
Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis. 2000 Apr;21(4):757-68.
St John LS, Sauter ER, Herlyn M, Litwin S, Adler-Storthz K. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53. Cancer Gene Ther. 2000 May;7(5):749-56.
Young NA, Ehya H, Klein-Szanto A, Litwin S, Smith MR, al-Saleem T. Differentiating large cell lymphoma from indolent small B-cell lymphoma in fine needle aspirates using p53, PCNA and transformed lymphocyte count. Acta Cytol. 2000 Jul;44(4):592-603.
Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS, Sauter ER. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer. 1999 Mar 15;85(6):1226-33.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Protein p53

Protein p53 Human metabolism genetics physiology US Gov't Support-PHS Non-US Gov't Support Mice Cell Cycle Animal Genetic Transcription Cell Line Apoptosis Female Promoter Regions (Genetics) Base Sequence pathology Tumor Suppressor Genes Cultured Tumor Cells Proto-Oncogene Proteins DNA Damage Cyclins Male Binding Sites Neoplastic Gene Expression Regulation chemistry Squamous Cell Carcinoma Gene Expression Regulation analysis DNA-Binding Proteins Transcription Factors Retinoblastoma Protein Neoplasms Molecular Sequence Data p53 Genes Proto-Oncogene Proteins c-bcl-2 Messenger RNA Time Factors Biological Models Hela Cells Protein Binding Paclitaxel Neoplasm Proteins Survival Rate Repressor Proteins Reverse Transcriptase Polymerase Chain Reaction me [Metabolism] Stem Cells pharmacology 0 (Protein p53) Treatment Outcome Multivariate Analysis cytology drug effects Complementary DNA Phosphorylation Signal Transduction methods Mutation Immunoblotting antagonists & inhibitors Neoplastic Cell Transformation Antineoplastic Agents Breast Neoplasms Phenotype DNA Primers DNA Repair Retrospective Studies Prognosis Adult Biological Tumor Markers Predictive Value of Tests Proteins radiation effects Gamma Rays Experimental Neoplasms Immunohistochemistry Trans-Activation (Genetics) Knockout Mice Survival Analysis Transcription Factor AP-1 Gene Expression Profiling Homeodomain Proteins Middle Aged Rats Genotype df [Deficiency] Differential Diagnosis RNA Tretinoin surgery CDC2 Protein Kinase 33069-62-4 (Paclitaxel) 80 and over Aged 23214-92-8 (Doxorubicin) Fibroblasts Cyclin-Dependent Kinases mammalian) 0 (MLH1 protein Recombinant Fusion Proteins aa [Analogs & Derivatives] 4342-03-4 (Dacarbazine) Keratinocytes NF-kappa B Polyacrylamide Gel Electrophoresis Immunophenotyping P-Glycoprotein mortality Proportional Hazards Models Large-Cell Lymphoma Dacarbazine Colon Phosphoric Monoester Hydrolases deficiency Oncogenes EC 3-6-1-3 (Adenosinetriphosphatase) US Gov't Research Support-PHS Drug Interactions Cytoprotection therapy Molecular Chaperones Prospective Studies etiology Laryngeal Neoplasms 0 (Neoplasm Proteins) Glycoproteins EC 6-5-1 (DNA Repair Enzymes) Cell Hypoxia Amino Acid Sequence Isoenzymes Adenosinetriphosphatase Simian virus 40 Colonic Neoplasms Randomized Controlled Trials Adenocarcinoma 0 (Isoenzymes) ge [Genetics] Cell Division cdc Genes 73-40-5 (Guanine) Adolescent Recombinant Proteins US Gov't Support-Non-PHS Fluorouracil Phytogenic Antineoplastic Agents Exons Cysteine Endopeptidases Neoplasm Transplantation chemical synthesis de [Drug Effects] Protein p16
Last updated on Thursday, November 02, 2017